Free Trial
NASDAQ:NAOV

NanoVibronix (NAOV) Stock Price, News & Analysis

$0.77
-0.01 (-1.29%)
(As of 07/19/2024 ET)
Today's Range
$0.75
$0.80
50-Day Range
$0.70
$0.86
52-Week Range
$0.67
$4.23
Volume
10,587 shs
Average Volume
65,658 shs
Market Capitalization
$2.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NAOV stock logo

About NanoVibronix Stock (NASDAQ:NAOV)

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.

NAOV Stock Price History

NAOV Stock News Headlines

China Stockpiling Gold “Like No Tomorrow”
For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… .
NanoVibronix Issues Letter to Stockholders
China Stockpiling Gold “Like No Tomorrow”
For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… .
NanoVibronix Issues Letter to Stockholders
NanoVibronix, Inc. (NAOV)
NanoVibronix Inc NAOV
NanoVibronix Featured in Your Bladder Health Magazine
See More Headlines
Receive NAOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NanoVibronix and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/15/2024
Today
7/19/2024
Next Earnings (Estimated)
8/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:NAOV
Employees
10
Year Founded
N/A

Profitability

Net Income
$-3,710,000.00
Net Margins
-112.35%
Pretax Margin
-111.16%

Debt

Sales & Book Value

Annual Sales
$2.85 million
Book Value
$1.95 per share

Miscellaneous

Free Float
2,684,000
Market Cap
$2.13 million
Optionable
Not Optionable
Beta
1.54
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Brian M. Murphy (Age 67)
    CEO & Director
    Comp: $342.5k
  • Mr. Stephen R. Brown CPA (Age 68)
    Chief Financial Officer
    Comp: $276.5k
  • Dr. Harold Jacob M.D. (Age 70)
    Chief Medical Officer & Director
  • Mr. Amir Rippel
    Vice President of Marketing
  • Ms. Lindsey Harrison
    Vice President of Sales

NAOV Stock Analysis - Frequently Asked Questions

How have NAOV shares performed this year?

NanoVibronix's stock was trading at $1.15 at the beginning of 2024. Since then, NAOV stock has decreased by 33.4% and is now trading at $0.7660.
View the best growth stocks for 2024 here
.

How were NanoVibronix's earnings last quarter?

NanoVibronix, Inc. (NASDAQ:NAOV) released its quarterly earnings results on Wednesday, May, 15th. The company reported ($0.23) EPS for the quarter. The company had revenue of $0.92 million for the quarter. NanoVibronix had a negative net margin of 112.35% and a negative trailing twelve-month return on equity of 95.96%.

When did NanoVibronix's stock split?

Shares of NanoVibronix split on the morning of Thursday, October 13th 2022. The 2-1 split was announced on Thursday, October 13th 2022. The newly minted shares were payable to shareholders after the closing bell on Thursday, October 13th 2022. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

How do I buy shares of NanoVibronix?

Shares of NAOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of NanoVibronix own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NanoVibronix investors own include T2 Biosystems (TTOO), ADMA Biologics (ADMA), Co-Diagnostics (CODX), Inovio Pharmaceuticals (INO), Tonix Pharmaceuticals (TNXP) and BIO-key International (BKYI).

This page (NASDAQ:NAOV) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners